University of Florida
Gainesville, Florida, 32610, United States
NCT Number: NCT04208269
Our project will assess the feasibility and estimate preliminary efficacy of a multilevel intervention to improve HPV vaccine series initiation among adolescents in Medicaid and CHIP. The investigators will use two intervention components: postcards and an iPad survey system. To estimate efficacy the investigators will select potential participants from Florida Medicaid and CHIP. The investigators will assess their claims for the HPV vaccine before and after the intervention.
Looking for future studies?
Notify Me11 year–18 year
All sexes
Interventional
Not applicable
Gainesville, Florida, 32610, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Post card sent to parent only
Accessed by adolescent and provider only
Time frame: Up to 5 months
The percent age eligible participants who initiate HPV vaccination.
Time frame: Up to 3 months
The percent age eligible participants received a preventive care visit
University of Florida
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05204030
Human Papilloma Virus, Infections
Fayetteville, Arkansas, United States
View Trial DetailsNCT03729518
Carcinoma, Carcinoma, Squamous Cell
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04716127
Cervical Cancer, Female Urogenital Diseases
Montpellier, Herault, France
View Trial DetailsNCT03943875
Efficacy, Human Papilloma Virus
Galveston, Texas, United States
View Trial Details